Actuate Therapeutics, Inc. (ACTU)
NASDAQ: ACTU · Real-Time Price · USD
2.900
+0.050 (1.75%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Actuate Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
| Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| Market Capitalization | 69 | 142 | 155 | - | - |
| Market Cap Growth | -50.48% | -8.51% | - | - | - |
| Enterprise Value | 56 | 125 | 142 | - | - |
| Last Close Price | 2.90 | 6.12 | 7.96 | - | - |
| PB Ratio | 8.51 | 17.95 | 1492.25 | - | - |
| P/TBV Ratio | 8.68 | 17.95 | 1492.25 | - | - |
| Net Debt / Equity Ratio | -1.66 | -1.66 | -82.94 | 0.66 | -1.31 |
| Quick Ratio | 2.31 | 2.31 | 0.98 | 0.43 | 4.71 |
| Current Ratio | 2.39 | 2.39 | 1.05 | 0.43 | 4.71 |
| Return on Equity (ROE) | -553.75% | -553.75% | - | -442.40% | - |
| Return on Assets (ROA) | -120.40% | -120.40% | -255.41% | -132.96% | - |
| Return on Capital Employed (ROCE) | -270.10% | -270.10% | -4876.60% | 636.30% | -125.20% |
| Earnings Yield | -32.32% | -15.63% | -17.55% | - | - |
| Buyback Yield / Dilution | -151.07% | -151.07% | -483.48% | -18.54% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.